As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Tom Arnold brings almost 25 years of extensive leadership experience in diabetes and medical technology and has a strong track record in spearheading commercialization initiatives, business strategy, and product launches for leading medical device companies. He has held key leadership roles at Medtronic, PROCEPT BioRobotics, Boston Scientific, and Sorin Group.
Dr. Samuel A. Joseph Jr. a leader in minimally invasive and complex spine surgery, will bring his wealth of experience and innovative approach to the academic setting, enhancing the educational experience of residents and medical professionals in the field of orthopedic surgery.
Dr Birgitte Volck has over 25 years of industry experience spanning R&D leadership, platform innovation, and commercialization, with a strong focus on rare diseases and precision medicine.
Suj Mehta assumes permanent leadership at a pivotal point in TekniPlex Healthcare’s evolution.
“I am excited to join Envisagenics at this pivotal stage in the company’s development,” said Sudhir Rao. “The company’s cutting-edge, AI-driven SpliceCore® platform identifies novel targets, paving the way for innovative treatments in oncology, neurodegenerative diseases, and beyond. I look forward to collaborating with the talented team to execute impactful partnerships, expand our relationships with investors and enable the development of groundbreaking therapies for patients.”
Vincent Renz has served most recently as the President and Founder of Straight4ward Advisory Services – a boutique professional services company. He is experienced with driving significant value creation for shareholders and delivering on both turnaround and growth strategies. In 2024, Renz joined Brand Craft Holdings in an advisory capacity to begin building the team to identify investment opportunities.